欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/4508/001
药品名称Dailiport 0,5 mg
活性成分
    • tacrolimus monohydrate 0.5 mg
剂型Prolonged-release capsule, hard
上市许可持有人Sandoz B.V. Veluwezoom 22 1327 AH Almere The Netherlands
参考成员国 - 产品名称Netherlands (NL)
Dailiport 0,5 mg, harde capsules met verlengde afgifte RVG 123565
互认成员国 - 产品名称
    • Denmark (DK)
      Dailiport
    • Belgium (BE)
      Dailiport 0,5 mg capsules met verlengde afgifte
    • Iceland (IS)
      Dailiport forðahylki
    • United Kingdom (Northern Ireland) (XI)
    • Austria (AT)
      Dailiport 0,5 mg - Hartkapseln, retardiert
    • Portugal (PT)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
      Dailiport
    • Latvia (LV)
      Dailiport 0,5 mg ilgstošās darbības cietās kapsulas
    • Lithuania (LT)
      Dailiport 0,5 mg pailginto atpalaidavimo kietosios kapsulės
    • Estonia (EE)
      DAILIPORT
    • Czechia (CZ)
      Dailiport
    • Slovakia (SK)
    • Slovenia (SI)
      Dailiport 0,5 mg trde kapsule s podaljšanim sproščanjem
    • Germany (DE)
      Dailiport 0,5 mg Hartkapseln, retardiert
许可日期2019/09/18
最近更新日期2024/08/22
药物ATC编码
    • L04AD02 tacrolimus
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase